» Articles » PMID: 35137524

Obesity Augments the Disease Burden in COVID-19: Updated Data from an Umbrella Review

Overview
Journal Clin Obes
Specialty Endocrinology
Date 2022 Feb 9
PMID 35137524
Authors
Affiliations
Soon will be listed here.
Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic calls for identification of risk factors, which may help to identify people at enhanced risk for severe disease outcomes to improve treatment and, if possible, establish prophylactic measures. This study aimed to determine whether individuals with obesity compared to individuals with normal weight have an increased risk for severe COVID-19. We conducted a systematic literature search of PubMed, Embase and Cochrane Library and critically reviewed the secondary literature using AMSTAR-2. We explored 27 studies. Findings indicate that individuals with obesity (body mass index ≥ 30 kg/m ), as compared to individuals without obesity, experience an increased risk for hospitalization (odds ratio [OR]: 1.40-2.45), admission to the intensive care unit (OR: 1.30-2.32), invasive mechanical ventilation (OR: 1.47-2.63), and the composite outcome 'severe outcome' (OR or risk ratio: 1.62-4.31). We found diverging results concerning death to COVID-19, but data trended towards increased mortality. Comparing individuals with obesity to individuals without obesity, findings suggested younger individuals (<60 years) experience a higher risk of severe disease compared to older individuals (≥60 years). Obesity augments the severity of COVID-19 including a tendency to increased mortality and, thus, contributes to an increased disease burden, especially among younger individuals.

Citing Articles

L-Fucose-Rich Sulfated Glycans from Edible Brown Seaweed: A Promising Functional Food for Obesity and Energy Expenditure Improvement.

Hyun J, Lee H, Je J, Choi Y, Song K, Kim T Int J Mol Sci. 2024; 25(17).

PMID: 39273687 PMC: 11395595. DOI: 10.3390/ijms25179738.


Contactless exercise intervention in prenatal and postnatal period during COVID-19 lowers the risk of postpartum depression.

Hwang D, Cho J, Hyun A Sci Rep. 2024; 14(1):9780.

PMID: 38684812 PMC: 11058814. DOI: 10.1038/s41598-024-60658-7.


Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review.

Beurton A, Kooistra E, De Jong A, Schiffl H, Jourdain M, Garcia B Curr Obes Rep. 2024; 13(3):545-563.

PMID: 38573465 DOI: 10.1007/s13679-024-00562-3.


Promoting healthy populations as a pandemic preparedness strategy: a simulation study from Mexico.

Johnson R, Carnalla M, Basto-Abreu A, Haw D, Morgenstern C, Doohan P Lancet Reg Health Am. 2024; 30:100682.

PMID: 38332937 PMC: 10850772. DOI: 10.1016/j.lana.2024.100682.


Associations of diabetes, hypertension and obesity with COVID-19 mortality: a systematic review and meta-analysis.

Li C, Islam N, Gutierrez J, Gutierrez-Barreto S, Prado A, Moolenaar R BMJ Glob Health. 2023; 8(12).

PMID: 38097276 PMC: 10729095. DOI: 10.1136/bmjgh-2023-012581.


References
1.
Ho J, Fernando D, Chan M, Sia C . Obesity in COVID-19: A Systematic Review and Meta-analysis. Ann Acad Med Singap. 2021; 49(12):996-1008. View

2.
Ong S, Young B, Leo Y, Lye D . Association of Higher Body Mass Index With Severe Coronavirus Disease 2019 (COVID-19) in Younger Patients. Clin Infect Dis. 2020; 71(16):2300-2302. PMC: 7239262. DOI: 10.1093/cid/ciaa548. View

3.
Naimark A, CHERNIACK R . Compliance of the respiratory system and its components in health and obesity. J Appl Physiol. 1960; 15:377-82. DOI: 10.1152/jappl.1960.15.3.377. View

4.
Camhi S, Bray G, Bouchard C, Greenway F, Johnson W, Newton R . The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring). 2010; 19(2):402-8. PMC: 3960785. DOI: 10.1038/oby.2010.248. View

5.
Perez de Heredia F, Gomez-Martinez S, Marcos A . Obesity, inflammation and the immune system. Proc Nutr Soc. 2012; 71(2):332-8. DOI: 10.1017/S0029665112000092. View